MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 58 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $481 | -41.6% | 3,040 | 0.0% | 0.00% | – |
| Q1 2024 | $824 | +25.4% | 3,040 | 0.0% | 0.00% | – |
| Q4 2023 | $657 | +66.3% | 3,040 | 0.0% | 0.00% | – |
| Q3 2023 | $395 | -63.9% | 3,040 | 0.0% | 0.00% | – |
| Q2 2023 | $1,094 | -23.4% | 3,040 | 0.0% | 0.00% | – |
| Q1 2023 | $1,429 | -6.0% | 3,040 | 0.0% | 0.00% | – |
| Q4 2022 | $1,520 | -24.0% | 3,040 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 3,040 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 3,040 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 3,040 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -25.0% | 3,040 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | +100.0% | 3,040 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | -100.0% | 3,040 | -50.0% | 0.00% | – |
| Q1 2021 | $6,384,000 | +159500.0% | 6,080 | +100.0% | 0.00% | – |
| Q4 2020 | $4,000 | +100.0% | 3,040 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 3,040 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 3,040 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 3,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 10,188,312 | $8,727,000 | 0.75% |
| Vivo Capital, LLC | 6,818,181 | $5,840,000 | 0.55% |
| Stonepine Capital Management, LLC | 668,615 | $573,000 | 0.40% |
| Telemetry Investments, L.L.C. | 574,619 | $492,000 | 0.38% |
| Broadfin Capital, LLC | 766,708 | $657,000 | 0.14% |
| Granite Point Capital Management, L.P. | 1,500,000 | $1,285,000 | 0.09% |
| STALEY CAPITAL ADVISERS INC | 200,000 | $171,000 | 0.01% |
| HYMAN CHARLES D | 79,800 | $68,000 | 0.01% |
| CRA Financial Services, LLC | 10,000 | $9,000 | 0.01% |
| BRIGHTON JONES LLC | 50,000 | $43,000 | 0.01% |